A clinical trial to evaluate the efficacy of Vishaghna dashemani in twak vikara (Skin diseases).

A CONCEPTUAL AND APPLIED STUDY ON VISHAGHNA DASHEMANI OF CARAKA SAMHITA VIS-A-VIS DUSHIVISHA JANYA TWAK VIKARA

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2021/03/031702

Enrollment

Registered

2021-03-04

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L988- Other specified disorders of the skin and subcutaneous tissue

Interventions

Intervention1: Internal medicine - Vishaghna Mahakashaya Ghanavati (Tablet): 1. Haridra 2. Manjishtha 3. Suvaha (Trivrut) 4. Sukshmela 5. Palindi (Rasna) 6. Candana 7. kataka 8. Shirisha 9. Sindhuva

Eligibility

Inclusion criteria

Inclusion criteria: Patients fulfilling Diagnostic Criteria.

Exclusion criteria

Exclusion criteria: 1. Patients not satisfying assessment criteria for dushivisha as a cause. 2. Pregnancy, Lactating women. 3. Patients suffering from major systemic disorders and on medications which would interrupt the study.

Design outcomes

Primary

Measure	Time frame
Improvement in the Symptoms.Timepoint: 4 weeks	—

Secondary

Measure	Time frame
improvements in the symptomsTimepoint: 6th week	—

Countries

India

Contacts

Public ContactDr Rohit Gavali

Government Ayurveda Medical College, Mysore.

dr.shreevathsa@rediffmail.com9449772701

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026